Aspirin in the prevention of cancer.

Wald, N J; Morris, J K; Law, M R

Wald, N J; Morris, J K; Law, M R.

Lancet ; 377(9778): 1649; author reply 1651-2, 2011 May 14.

Article in En | MEDLINE | ID: mdl-21571138

Subject(s)

Anticarcinogenic Agents/administration & dosage; Antihypertensive Agents/administration & dosage; Aspirin/administration & dosage; Cardiovascular Diseases/epidemiology; Cardiovascular Diseases/prevention & control; Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage; Neoplasms/epidemiology; Neoplasms/prevention & control; Age Distribution; Age Factors; Aged; Aged, 80 and over; Cardiovascular Diseases/mortality; Drug Combinations; England/epidemiology; Hemorrhage/chemically induced; Humans; Meta-Analysis as Topic; Middle Aged; Neoplasms/mortality; Randomized Controlled Trials as Topic; Wales/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Aspirin / Anticarcinogenic Agents / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Neoplasms / Antihypertensive Agents Type of study: Clinical_trials / Systematic_reviews Limits: Aged / Aged80 / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Lancet Year: 2011 Type: Article

Fulltext

XML

PubMed Links

Search on Google